{"id":"https://genegraph.clinicalgenome.org/r/b8d360b8-d571-4818-ad4d-e6d7eca037b2v3.0","type":"EvidenceStrengthAssertion","dc:description":"*CCDC50* was first reported in relation to autosomal dominant nonsyndromic hearing loss in 2007 (Modamio-Hoybjor et al., PMID:17503326). Four variants (missense, frameshift) that have been reported in 4 probands in 4 publications (PMIDs: 17503326, 34416374, 33229591, 37165931) are included in this curation. Variants in this gene segregated with disease in 14 additional family members (PMID:17503326). The mechanism of pathogenicity is unknown. This gene-disease association is also supported by an expression study (PMID:17503326). A knockdown mouse model showed no difference in auditory brainstem response thresholds between mutants and controls, so it was not scored (PMID: 37165931). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally evaluated by the ClinGen Hearing Loss GCEP on 12/15/2017 as per SOP v6. It was reevaluated on 6/25/2024 using SOP v10. As a result of this reevaluation, this record underwent an update in scoring to be consistent with SOP v10. New case level and functional evidence has been reviewed or added, but the classification did not change (PMIDs: 34416374, 33229591, 37165931). \n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b8d360b8-d571-4818-ad4d-e6d7eca037b2","GCISnapshot":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7","calculatedEvidenceStrength":"Limited","changes":[{"id":"cg:newEvidence"},{"id":"cg:otherTextChange"},{"id":"cg:summaryChange"},{"id":"cg:sopChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2024-06-25T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2024-08-07T15:44:51.523Z","role":"Publisher"}],"curationReasons":["RecurationCommunityRequest"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a0d36db7-5ae4-4b37-94f0-3af67f266022","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf802ee4-8c06-4b89-b91e-3627c914fec7","type":"Finding","dc:description":"RT-PCR on mouse cochlea mRNA revealed CCDC50 expression in the mouse inner ear prenatally, at birth, and 14 days postnatal. Immunofluorescent localization of the Ymer protein product of CCDC50 revealed that Ymer is a soluble cytoplasmic protein","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17503326","rdfs:label":"Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78872363-3cce-4876-9091-263ed36b6a9a","type":"EvidenceLine","dc:description":"Mutant mouse showed normal ABR thresholds","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cd8a8b31-c673-42f6-8e19-e2953f1c13ef","type":"Finding","dc:description":"In mature mice aged 14â€…weeks, they found no difference in auditory brainstem response (ABR) thresholds between homozygous mutants, heterozygotes and wildtype littermates. Ccdc50tm1a homozygous mouse mutant, with only 30% of the normal transcript levels, has normal ABR thresholds. They also generated a more severe allele; Ccdc50tm1b allele in which exon 3 and part of the inserted cassette are deleted. No difference in ABR thresholds was observed between Ccdc50tm1b homozygotes, heterozygotes and control littermate mice at 14 weeks and 6 months of age","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165931","rdfs:label":"Lachgar-Ruiz mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f489da5-6d6a-42cf-a558-4a842fb418b5","type":"EvidenceLine","dc:description":"Little information is provided about proband. Proband was part of a recessive HL cohort, so it is not entirely clear that the individual was heterozygous.\n","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f489da5-6d6a-42cf-a558-4a842fb418b5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27068579","allele":{"id":"https://genegraph.clinicalgenome.org/r/ced5c44f-150e-4126-b449-4de846470f1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.2(CCDC50):c.777_778insTAAT (p.His260Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658820634"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/49c3ca1e-7d6d-4009-b2f7-4883884a9b79","type":"EvidenceLine","dc:description":"This variant has been identified in 0.079% (940/1179878) in non-Finnish European alleles in gnomAD v4, which is likely too frequent for AD hearing loss","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49c3ca1e-7d6d-4009-b2f7-4883884a9b79_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24875298","allele":{"id":"https://genegraph.clinicalgenome.org/r/0b8dee15-85df-456a-b2ab-721349678103","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.3(CCDC50):c.227G>A (p.Arg76His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2755185"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/a6586fb9-3ee1-4da2-88a5-872eeb1d9123","type":"EvidenceLine","dc:description":"Downgraded as it is unclear who was sequenced. The variant also escapes NMD","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6586fb9-3ee1-4da2-88a5-872eeb1d9123_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17503326","allele":{"id":"https://genegraph.clinicalgenome.org/r/b0ebfd06-a718-4fc7-8742-b50e9b1e4949","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.3(CCDC50):c.1394_1401dup (p.Phe468HisfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA916084410"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a6586fb9-3ee1-4da2-88a5-872eeb1d9123_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunocytochemistry of NIH3T3 cells showed that the mutant generates protein tails and leads to aggregated perinuclear distribution","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/cf656dcb-6644-41bb-a29a-d7bdf54b28f7_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7778768-7bcf-460c-b2e3-b9cfac328fcf_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17503326","rdfs:label":"Spanish Family","estimatedLodScore":4.21,"family":{"id":"https://genegraph.clinicalgenome.org/r/f7778768-7bcf-460c-b2e3-b9cfac328fcf","type":"Family","rdfs:label":"Spanish Family","member":{"id":"https://genegraph.clinicalgenome.org/r/5889b8a5-fb43-4fa6-9bb8-2f8ad4884605","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17503326","rdfs:label":"Spanish Family Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/b0ebfd06-a718-4fc7-8742-b50e9b1e4949"},"detectionMethod":"Linkage analysis. CCDC50 was candidate gene based on expression in mouse cochlea. Three other genes (not specified) in interval were ruled out","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000408","obo:HP_0008596","obo:HP_0008619"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a6586fb9-3ee1-4da2-88a5-872eeb1d9123_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":14,"phenotypePositiveAllelePositive":15,"phenotypes":["obo:HP_0000408","obo:HP_0008596","obo:HP_0008619"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5889b8a5-fb43-4fa6-9bb8-2f8ad4884605"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/20147660-cc86-4e05-b432-5c207e02e50c_proband_segregation","type":"FamilyCosegregation","dc:description":"Only two family members were sequenced (out of four affected individuals), which is not enough to count.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24875298","rdfs:label":"D4","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/20147660-cc86-4e05-b432-5c207e02e50c","type":"Family","rdfs:label":"D4","member":{"id":"https://genegraph.clinicalgenome.org/r/1f6a21e1-848e-4ec4-8ff2-6444ef674753","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24875298","rdfs:label":"I:4","allele":{"id":"https://genegraph.clinicalgenome.org/r/0b8dee15-85df-456a-b2ab-721349678103"},"detectionMethod":"Two NGS panels that had either 80 or 129 deafness associated genes were used.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Moderate midgrade hearing loss since birth","phenotypes":"obo:HP_0008504","previousTesting":true,"previousTestingDescription":"All probands were screened and negative for GJB2 variants by Sanger.","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/49c3ca1e-7d6d-4009-b2f7-4883884a9b79_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Moderate midgrade hearing loss since birth","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0008504","proband":{"id":"https://genegraph.clinicalgenome.org/r/1f6a21e1-848e-4ec4-8ff2-6444ef674753"}},{"id":"https://genegraph.clinicalgenome.org/r/a012b67b-84f1-480f-86ff-bf1a8398f9ff_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165931","rdfs:label":"Spanish family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/a012b67b-84f1-480f-86ff-bf1a8398f9ff","type":"Family","rdfs:label":"Spanish family","member":{"id":"https://genegraph.clinicalgenome.org/r/30fd52c5-c74f-4dcc-a8dd-28ec66868c3f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165931","rdfs:label":"Spanish proband III:2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":29,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1b07c115-45bd-4c81-9b55-fb848cd77d87","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.3(CCDC50):c.1356_1386del (p.Asp452GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573136842"}},"detectionMethod":"custom-designed next-generation sequencing (NGS) panel (OTO-NGS-panel V1)","firstTestingMethod":"Next generation sequencing panels","phenotypes":["obo:HP_0008596","obo:HP_0005101","obo:HP_0001730","obo:HP_0008504"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c2d9103b-2b28-45e4-ad15-34c2a872edf5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165931","allele":{"id":"https://genegraph.clinicalgenome.org/r/1b07c115-45bd-4c81-9b55-fb848cd77d87"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0008504","obo:HP_0008596","obo:HP_0001730","obo:HP_0005101"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/30fd52c5-c74f-4dcc-a8dd-28ec66868c3f"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c2d9103b-2b28-45e4-ad15-34c2a872edf5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2d9103b-2b28-45e4-ad15-34c2a872edf5_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/c2d9103b-2b28-45e4-ad15-34c2a872edf5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Immunocytochemistry of NIH3T3 cells showed that the mutant generates protein tails and leads to aggregated perinuclear distribution","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8ec0d6e3-9dfe-4073-bb63-2e8cd521bdd1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ec0d6e3-9dfe-4073-bb63-2e8cd521bdd1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33229591","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b888092-dd53-4e22-bdb5-03d837554b89","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.3(CCDC50):c.167T>G (p.Leu56Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA355761161"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f9721733-f8c8-4942-aa56-c6c4780ade3b","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9721733-f8c8-4942-aa56-c6c4780ade3b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34416374","allele":{"id":"https://genegraph.clinicalgenome.org/r/1b004072-e500-4d16-949d-8779ed188238","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.3(CCDC50):c.679C>T (p.Arg227Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA89778671"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/070ab667-adc4-4d47-9f6e-fd45a68c4e0b","type":"EvidenceLine","dc:description":"The variant is present in 0.018% (8/44874) in East Asian alleles which is too frequent to be pathogenic. There is also little familial or phenotypic information provided.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/070ab667-adc4-4d47-9f6e-fd45a68c4e0b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27911912","allele":{"id":"https://genegraph.clinicalgenome.org/r/186a8c73-428c-46f0-b779-b87a18d98063","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_178335.2(CCDC50):c.820C>T (p.Arg274Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA89778705"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":3.7}],"evidenceStrength":"Limited","sequence":8771,"specifiedBy":"GeneValidityCriteria10","strengthScore":4.2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/_MAGe3izQsE","type":"GeneValidityProposition","disease":"obo:MONDO_0019497","gene":"hgnc:18111","modeOfInheritance":"obo:HP_0000006"},"version":"3.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_cf656dcb-6644-41bb-a29a-d7bdf54b28f7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}